logo
ResearchBunny Logo
CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection

Biology

CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection

Z. Liu, X. Gao, et al.

This groundbreaking study reveals a novel CRISPR-Cas13d-based strategy with over 99% efficiency in targeting SARS-CoV-2 variants, including Delta and Omicron. Conducted by a team of experts including Zongzhi Liu, Xiang Gao, and others, this research highlights the rapid antiviral potential of this approach, paving the way for future defenses against viral threats.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny